CAS 2561414-56-8

Formel: C24H30N6O2

InChl: InChI=1S/C24H30N6O2/c1-2-28-9-11-29(12-10-28)24(31)27-23-15-18(3-8-26-23)21-17-30(19-5-13-32-14-6-19)22-16-25-7-4-20(21)22/h3-4,7-8,15-17,19H,2,5-6,9-14H2,1H3,(H,26,27,31)

InChI Key: SAZIAQSVBIWIDU-UHFFFAOYSA-N

SMILES: CCN1CCN(CC1)C(=O)NC2=NC=CC(=C2)C3=CN(C4=C3C=CN=C4)C5CCOCC5

GNF2133

CAS: 2561414-56-8

GNF2133

Formel: C₂₄H₃₀N₆O₂

Reinheit: 98.5%

Molekulargewicht: 434.53

Ref: 54-BUP05266

GNF2133

CAS: 2561414-56-8

GNF2133 is an effective and selective inhibitor of DYRK1A with IC50s of 6.2 nM. GNF2133 can be used in studies about type 1 diabetes.

Formel: C₂₄H₃₀N₆O₂

Reinheit: 98.51%

Farbe und Form: Solid

Molekulargewicht: 434.534

Ref: TM-T40187

4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-carboxamide

CAS: 2561414-56-8

Formel: C₂₄H₃₀N₆O₂

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 434.5340

Ref: IN-DA023ODR

GNF2133

CAS: 2561414-56-8

4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-carboxamide

Formel: C₂₄H₃₀N₆O₂

Reinheit: 98%

Molekulargewicht: 434.53

Ref: IN-DG01521774